Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Aurobindo Pharma Ltd.
NSE: AUROPHARMA
|
BSE: 524804
|
ISIN: INE406A01037
|
Industry: Pharmaceuticals
Regulatory Impact
|
Mid-range Performer
1157.6000
-39.50
(
-3.30
%)
NSE
May 08, 2025
15:31 PM
27.29% Fall from 52W High
Volume:
996.5K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Aurobindo Pharma Ltd.
19 Nov 2024
Regulatory Impact
1157.60
-3.30%
Aurobindo Pharma Limited
Buy:
Aurobindo Pharma Ltd.
by
ICICI Direct
Target: 1580 | Upside : 36.5%
Target
ICICI Direct
Aurobindo Pharma Ltd. has an
average target
of 1501.00 from 10 brokers.
More from Aurobindo Pharma Ltd.
Recommended
Market closes lower, Asian Paints' Q4 revenue misses Forecaster estimates by 3.5%
Trendlyne Marketwatch |
08 May 2025, 04:03PM
Superstar investor portfolios take a hit from market volatility | Screener: Promoters reducing their stakes
The Baseline |
08 May 2025, 12:37AM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
|
15 Jul 2020